TipRanks
Go Ultimate55% OFF

Glenmark Pharmaceuticals Limited (GLENMARK) Balance Sheet

Glenmark Pharmaceuticals Limited Balance Sheet

Glenmark Pharmaceuticals Limited's total assets for Q4 2026 were $199.08B. IN:GLENMARK total liabilities were $93.96B for the fiscal quarter, a 198.06% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetMar 26Mar 25Mar 24Mar 23Mar 22
$ 199.08B$ 160.50B$ 143.59B$ 193.72B$ 170.83B
$ 93.96B$ 72.00B$ 65.11B$ 95.32B$ 76.45B
$ 105.12B$ 88.49B$ 78.48B$ 98.39B$ 94.38B

Currency in INR

Glenmark Pharmaceuticals Limited Debt to Assets

080B160B240B40 %48 %56 %64 %LiabilitiesDebt to Assets2017201820192020202120222023202420252026AssetsLiabilitiesDebt to Assets